Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Von willebrand factor but not tissue factor or soluble CD40 ligand are associated with increased risk of recurrent events after ACS in PROVE-IT-TIMI 22

Von willebrand factor but not tissue factor or soluble CD40 ligand are associated with increased risk of recurrent events after ACS in PROVE-IT-TIMI 22. J Am Coll Cardiol. 2007; 49(9 (Suppl A)):188A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.